Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $37.71 Average PT from Analysts
Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have received an average rating of “Moderate Buy” from the seven analysts that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price […]